Zhejiang Jingxin Pharmaceutical Co., Ltd.

Zhejiang Jingxin Pharmaceutical Co., Ltd. faced a significant decline in its stock price, dropping 4.76% on March 23, 2026. The stock has decreased notably over the past week and month, while year-to-date performance shows a larger decline compared to the broader market. However, the company reported a positive annual return.

Zhejiang Jingxin Pharmaceutical Co., Ltd. saw a significant stock decline today, contrasting with the broader market. Despite a year-to-date drop, the company has achieved a positive annual return. Financial metrics indicate steady growth in net sales and operating profit over the past five years, reflecting industry trends.

Zhejiang Jingxin Pharmaceutical Co., Ltd. saw a significant intraday increase on March 10, 2026, outperforming the China Shanghai Composite. Despite a recent uptick, the stock has faced challenges year-to-date. The company has a market capitalization of CNY 12,025 million and a price-to-earnings ratio of 23.00.